Objective: To investigate the pathogenic properties of Helicobacter pylori by comparing the proteome map of H. pylori clinical strains. Methods: Two wild-type H. pylori strains, YN8 (isolated from biopsy tissue of a gastric cancer patient) and YN14 (isolated from biopsy tissue of a gastritis and duodenal ulcer patient), were used. Proteomic analysis, using a pH range of 3-10 and 5-8, was performed. The individual proteins were identified by quadrupole time-of-flight (Q-TOF) mass spectrometer and protein database search. Results: Variation in spot patterns directed towards differential protein expression levels was observed between the strains. The gel revealed prominent proteins with several protein "families". The comparison of protein expressions of the two strains reveals a high variability. Differentially present or absent spots were observed. Nine differentially expressed protein spots identified by Q-TOF included adenosine triphosphate (ATP)-binding protein, disulfide oxidoreductase B (DsbB)-like protein, N utilization substance A (NusA), ATP-dependent protease binding subunit/heat shock protein, hydantoin utilization protein A, seryl-tRNA synthetase, molybdenum ABC transporter ModD, and hypothetical proteins. Conclusions: This study suggests that H. pylori strains express/repress protein variation, not only in terms of the virulence proteins, but also in terms of physiological proteins, when they infect a human host. The difference of protein expression levels between H. pylori strains isolated from gastric cancer and gastritis may be the initiator of inflammation, and result in the different clinical presentation. In this preliminary study, we report seven differential proteins between strains, with molecule weights from approximately 10 kDa to approximately 40 kDa. Further studies are needed to investigate those proteins and their function associated with H. pylori colonization and adaptation to host environment stress.
Introduction
Gastric cancer is the fourth most common cancer and the second most common cause of cancer deaths (Parkin et al., 2005) . There is a multistep progression stage from pre-malignancy to invasive malignancy.
Thus, early gastric cancer diagnosis for effective preventive strategies and therapeutics against gastric cancer is urgently required. Many epidemiological studies have shown a positive relationship between Helicobacter pylori infection and the risk for gastric cancer. Experimental studies using Mongolian gerbils showed that H. pylori infection increases the risk for gastric cancer (Kikuchi, 2002 The bacterium H. pylori was first isolated from a patient with active chronic gastritis in 1983 (Marshall and Warren, 1984) . It is now clear that H. pylori inflammation is associated with stomach disease, such as gastritis, gastric and duodenal ulcer, and gastric cancer. The detection of H. pylori in clinical practice is generally by either an invasive method, requiring endoscopy (Hp culture, histology, and urease test of biopsy) or via non-invasive methods ( 13 C/ 14 C-urea breath test, Hp antibody serological test, PCR-Hp-DNA test, and Hp stool antigen (HpSA)).
The mechanism by which H. pylori infection induces carcinogenesis is still unclear. The evidence comes mainly from epidemiological studies supporting that the risk for development of stomach diseases is higher in persons infected with cag pathogenicity island (cagPAI)-positive H. pylori than in those infected with cagPAI-negative strains (Blaser et al., 1995; van Doorn et al., 1998; Blaser and Berg, 2001) . After cytotoxin-associated antigen (CagA) encoded by the cagPAI is translocated into gastric epithelial cells, it causes cellular alterations, including cell morphological changes, dephosphorylation of CagA protein, and increased levels of interleukin-8 (IL-8) (Zhang et al., 2009) . Gastric epithelial cell damage may be a consequence of the inflammatory responses induced by H. pylori infection. cagA and iceA have been proposed as biomarkers that might predict the risk for symptomatic clinical outcomes. However, they cannot explain why H. pylori strains isolated from asymptomatic patients have also the same frequency of expression of both CagA and VacA compared to the strains isolated from patients with peptic ulcer or gastric cancer (Park et al., 1998; Yamaoka et al., 1999) . Neither iceA nor assembly of iceA/vacA/cagA is helpful in predicting the clinical presentation infected with H. pylori. H. pylori strainspecific factors may influence the pathogenicity of different H. pylori isolates and the presentation of a clinical outcome. There should be other proteins/ factors cooperating with CagA and VacA to induce or promote the development of disease.
The complete genome of strains (Tomb et al., 1997; Alm et al., 1999) provides sufficient genetic information for proteome analysis of H. pylori. Proteome technology employs protein separation by two-dimensional gel electrophoresis (2-DE) followed by identification using mass spectrometry (MS) methods (Jungblut et al., 2000; Graves and Haystead, 2002; Govorun et al., 2003; Friedman et al., 2009; Schmidt et al., 2009 ). The fact that 35 genes of H. pylori 11637 translate 93 proteins (Lock et al., 2001) suggests that H. pylori proteins express a high degree of post-translational modification. A comparative proteome map of H. pylori strains should be beneficial to investigate the pathogenic properties of these organisms. In this preliminary study, by comparing 2-DE proteome maps of H. pylori isolates obtained from gastric cancer and gastritis, we evaluate the variability of the protein expression level between the two strains.
Materials and methods

H. pylori strains
Two wild-type H. pylori strains, YN8 (isolated from biopsy tissue of a gastric cancer patient) and YN14 (isolated from biopsy tissue of a gastritis and duodenal ulcer patient), were used in this study. The isolates were confirmed by microscopy, culture, and rapid urease test (Sanqiang Biochemistry, Fujian, China).
H. pylori and protein preparations
H. pylori strains were grown on Columbia agar base (Oxoid Ltd.) including amphotericin B (2.5 μg/ml), trimethoprim (2.5 μg/ml), and vancomycin (5 μg/ml) supplemented with 10% sheep blood at 37 °C in a microaerobic condition (GENbox, bioMérieux) . Then H. pylori clones were cultivated in Brucella broth (Becton Dicknson) containing 10% horse serum. Bacteria were washed in phosphatebuffered saline (PBS) (Govorun et al., 2003) . The pellet of bacteria was lysed with lysis buffer (0.04 g/ml 3- [(3-cholamidopropyl) 
Bio-Lyte, proteinase inhibitor) for 15 min. The suspension was sonicated (Microson™ Ultrasonic Cell Disruptor) for 20 s and followed by centrifugation at 1 500 r/min for 60 min. The supernatants were removed and stored at −80 °C.
Protein assay
Protein concentrations were detected by a protein assay kit (Bio-Rad). In brief, 10 μl of sample and bovine serum albumin (BSA) control sample (0.4 mg/ml) were added to a 96-cell microplate. Then 200 μl of diluted dye reagent was added. The microplate was mixed and incubated at room temperature for at least 5 min. Protein concentrations were calculated by measurement of absorbance at 595 nm (CERES 900 Bio-Tek Instruments Inc.) with BSA as a standard.
Two-dimensional gel electrophoresis
First-dimensional runs were performed using nonlinear immobilized pH gradient (IPG) strips (Bio-Rad). Protein was loaded into isoelectric focusing (IEF) gel (pI 5-8) (Bio-Rad). A total of 100 μg of protein and 1 mg of protein were used for silver staining and Coomassie brilliant blue staining, respectively. Protein equilibrium and isoelectrofocusing were carried as described previously (Govorun et al., 2003) . For second-dimensional runs, 10% gel was used according to molecular weight. The proteins were detected by silver staining for analysis and by Coomassie brilliant blue staining for identification. The PDQuest software (Bio-Rad) was used for protein spot matching analysis.
In-gel digestion
According to recommended protocols (Bio-Rad), gel fragments (1 mm 3 ) were cut out of the protein spots stained with Coomassie using a sterilized knife. Each fragment was washed twice in 200 μl of 50% (v/v) acetonitrile (CH 3 CN), then washed in 100 mmol/L NH 4 HCO 3 containing 30% CH 3 CN for 45 min, 50 mmol/L NH 4 HCO 3 containing 50% CH 3 CN for 30 min, and 25 mmol/L NH 4 HCO 3 containing 50% CH 3 CN for 20 min. Each dried gel fragment was treated with 10 μl of trypsin (20 ng/μl) (Promega, USA), and then incubated in 20 μl of NH 4 HCO 3 (25 mmol/L) at 37 °C for 20 h. After the trypsinolysis, gel fragments were incubated in 50 μl of H 2 O for 10 min. Supernatant was collected in separate tubes with 50 μl of 5% (v/v) trifluoroacetic acid (TFA) in 60% (v/v) CH 3 CN for 15 min. Samples, concentrated to a final volume 10 μl with 5% TFA in 60% CH 3 CN, were used for mass spectrometry analysis.
Quadrupole time-of-flight (Q-TOF) mass spectrometry analysis and database search
The peptide analysis was carried out as per protocols of the supplier (Bio-Rad). Mass spectra were obtained using the Q-TOF mass spectrometer (Q-TOF Ultima Global mass spectrometer; Waters USA). MS/MS data were searched against NCBInr protein sequence databases (http://www.ncbi.nlm. nih.gov) and Mascot (http://www.matrixscience.com).
Results
Protein expression of H. pylori strain
The protein compositions of H. pylori YN8 and YN14 were initially separated on 2-DE gel stained by silver staining (Fig. 1) . The protein spots were Although several main spots/clusters were found at the same position, some proteins visually varied in expression level. Spots around the same pI and M r were present/absent or strong/weak on the proteome maps of H. pylori YN8 and YN14.
Protein identification
Because most expressed proteins were spread over the center of pI 3-10 gel, we further selected the 2-DE experiments of pI 5-8. The protein comparison of the two strains showed a high variability. High-intensity spots per gel were distinguishable. The differentially expressed protein spots by comparing the two strain proteome maps were excised from the gel stained by Coomassie brilliant blue (circled spots in Fig. 2 ). Then Q-TOF was performed for protein identification with statistical confidence (Fig. 3) . Spot Nos. 1 and 2 showed heavier intensity in YN8 than in YN14. Spot Nos. 3, 4, and 5 were present in YN8, but absent in YN14. Spot Nos. 6, 7, 8, and 9 were shown in YN14, but not in YN8. Seven of nine protein spots identified using protein database (http://www.ncbi. nlm.nih.gov) are adenosine triphosphate (ATP)-binding protein, disulfide oxidoreductase B (DsbB)-like protein, N utilization substance A (NusA), ATPdependent protease binding subunit/heat shock protein, hydantoin utilization protein A, seryl-tRNA synthetase, molybdenum ABC transporter ModD, and hypothetical proteins (Table 1) . Interestingly, the same amino acid sequence has different protein definition depending on individual strain, e.g., IVES-DAITALIQR definition is hydantoin utilization protein A in H. pylori HPKX, and hypothetical protein in H. pylori B128. Two of nine proteins are unknown. Fig. 2 . Symbols "↑" or "↓" show increased or reduced protein expression intensity, respectively; Symbols "+" or "−" show the presence or absence of a corresponding protein spot on the 2-DE map, respectively
Discussion
It is well known that H. pylori strains display a high interstrain genomic divergence (Salama et al., 2000) . This high variation at the genomic level does not provide evidence of a functional protein difference between strains because silent mutations happen naturally. Disordered proteins are considered as disorder-promoting and disease-initiating factors. Thus, we focused on protein expression levels of H. pylori isolates. From this study, different H. pylori isolates have individual protein expression levels. The presence or absence of some protein spots on 2-DE was thought to be useful for H. pylori infection characterization. The strain-specific proteins act synergistically with virulence factors to reside for decades in the niche of the human stomach, to modulate adaptations to diverse hosts, to cause bacterial persistent infection in hosts, and, finally, to induce different disease outcomes. We speculated that disease-specific proteins were thought to be responsible for the clinical presentation induced by H. pylori infection. However, none of the seven identified proteins showed similarities with virulence factors reported in previous studies (Govorun et al., 2003; Zhang et al., 2009) . For example, (1) it has been established that Dsb family (DsbA, DsbB, DsbC, DsbD, and DsbG) of redox proteins is involved in correct formation of disulfide bond into proteins in the periplasm or assembly of many pathogenic virulence factors (Raczko et al., 2005) . Many bacteria use an oxidative protein-folding machinery to assemble proteins that are necessary for cell integrity and to produce virulence factors. Because dsb gene mutations change disulfide bond formation and stability of some extracytoplasmic proteins, Dsb protein is not stable and results in attenuation of pathogens. The interesting thing is that H. pylori isolated from gastric cancer showed present or high increased DsbB-like protein compared to that of the strain isolated from gastritis. This infers that a strain which produces much more redox proteins when it colonizes human gastric mucosa for life may portend a higher risk for gastric cancer. This hypothesis needs further study. (2) NusA modulates transcriptional pausing, termination, and antitermination (Paliy et al., 2008; Prasch et al., 2009; Cohen et al., 2009; Fig. 3 Identification of protein of Spot 5 by mass spectrometry Probability-based Mowse score of Spot 5 is shown. Ions score is −10×logP, where P is the probability that the observed match is a random event. Individual ion scores >54 indicate identity or extensive homology (p<0.05). Protein scores are derived from ion scores as a non-probabilistic basis for ranking protein hits (Ha et al., 2010) . NusA is also a crucial participant in the phenomenon of stress-induced mutagenesis . This suggests that bacterium can modulate itself gene transcription in response to stress in a host. (3) Aminoacyl-tRNA synthetases (aaRSs) are enzymes that catalyze the correct attachment of amino acids to their cognate tRNAs in protein synthesis (Lenhard et al., 1999; Tumbula et al., 1999) . SeryltRNA synthetase in Escherichia coli is a homodimeric class II aaRS (Vincent et al., 1995) . In most pathogenic bacteria, aaRSs are antimicrobial drug targets for screening and designing enzyme inhibitors, such as the antibiotic pseudomonic acid, an inhibitor of bacterial isoleucyl-rRNA synthetase, which has been used clinically as an agent to prevent Staphylococcus aureus infection. aaRS genes may have physiological roles in dealing with harsh environments or be directly involved in biosynthetic pathways (Zeng et al., 2009) . Godinic-Mikulcic et al. (2011) reported that methanogenic archaea can optimize an early translation step by tRNA-synthetase complex under extreme environmental conditions. (4) Molybdenum plays an important role not only in the iron-molybdenum cofactor of nitrogenase, but also in the molybdopterin cofactor of all other molybdoenzymes. mod genes (modA, modB, modC, and modD) encode a binding-protein-dependent molybdate transport system. Rhodobacter capsulatus and E. coli modD genes, which are located at a downstream of modABC gene, encode a 259-amino acid and 231-amino-acid protein, respectively (Wang et al., 1993; Maupin-Furlow et al., 1995) . Fourfold-higher molybdenum concentrations can inhibit the activity of the alternative nitrogenase in R. capsulatus modD mutants, whereas an increase of up to 500-fold is needed for modC, modB, and modA mutants. This indicates that R. capsulatus ModD is involved either in molybdenum transport or in signal transduction (Wang et al., 1993) . Compared to the wild-type strain, a mutation in or deletion of E. coli modD gene shows no apparent phenotype difference, suggesting that ModD is not necessary for the molybdate transport system. The mod operon is very poorly expressed in the wild-type mod + strain, but elevated in a molybdate transport mutant strain or in the wild-type strain growing in a molybdate-deficient medium. This infers that the mod operon is repressed in the presence of molybdate. There is no information on the possible physiological functions of ModD protein. The studies of NusA, seryl-tRNA synthetase, and ModD protein mentioned above in H. pylori have received little attention thus far. Taylor et al. (1992) speculated that H. pylori strains undergo genomic rearrangements to adapt to a new human host environment. The results presented here suggest that H. pylori strains express/repress proteins variation, not only in terms of the virulence proteins, but also in terms of physiological proteins when they infect a human host. This raises a question concerning the significance of these proteins in H. pylori infection. It is tempting to speculate that these proteins may be involved in disease development during H. pylori infection. This linker is predicted to be intrinsically disordered. Disordered proteins may carry out the essential control and regulation functions that are needed to respond to the various environmental conditions, and our analysis of proteins seems to support such hypothesis. If this was the case, it can explain asymptomatic vacA + cagA + H. pylori carriers during a long bacterial infection. This idea remains to be further tested. For the two unknown proteins, we speculate that spots appearing well separated on a gel may consist of several proteins. The number of the proteins' mass peaks in peptide mass fingerprinting increased dramatically, such that the spot cannot be identified from an assigned database.
Because the 2-DE technique is too laborious and expensive (Enroth et al., 2000) , comparative analysis of proteins is, to date, a better method to find a new disease-specific protein antigen (Backert et al., 2005) . The new specific proteins may be used to find proteins as biomarkers for diagnosis of diseases, and therapy, to monitor diseases associated with H. pylori infection. In this preliminary study, we confirm the variation, at the protein level, of H. pylori isolated from patients with gastric cancer and gastritis. This reveals completely unexpected complexity and diversity in protein expression. The individual protein expression/repression related to inflammation may be result in the different outcomes of diseases induced by H. pylori infection.
